Source: China – South China Morning PostChina’s CanSino Biologics may start a clinical trial as early as next month using Russia’s Sputnik V vaccine followed by a shot of its own Covid-19 vaccine, a senior executive said late on Thursday.Combined dosage may help address a global shortage of the two-dose Sputnik V, which adopts a similar technique as the Chinese company’s product, said Pierre Morgon, senior vice-president at CanSinoBIO.“[The combined use] is something that several countries have been asking for because the Russians…Read More